CODULLO, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 781
EU - Europa 600
AS - Asia 331
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 1.723
Nazione #
US - Stati Uniti d'America 777
CN - Cina 306
IE - Irlanda 258
FI - Finlandia 69
DE - Germania 64
AT - Austria 54
IT - Italia 44
UA - Ucraina 38
SE - Svezia 28
IN - India 12
CZ - Repubblica Ceca 10
GB - Regno Unito 9
BE - Belgio 8
JP - Giappone 8
FR - Francia 7
CA - Canada 4
MK - Macedonia 4
RU - Federazione Russa 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EU - Europa 2
MU - Mauritius 2
NL - Olanda 2
SG - Singapore 2
ZM - Zambia 2
AU - Australia 1
DK - Danimarca 1
HK - Hong Kong 1
IQ - Iraq 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 1.723
Città #
Dublin 255
Chandler 232
Nanjing 84
Jacksonville 70
Ashburn 68
Beijing 50
Vienna 50
Helsinki 43
Princeton 37
Lawrence 36
Nanchang 34
Medford 29
Shanghai 29
Shenyang 27
Wilmington 25
New York 21
Pavia 19
Jiaxing 17
Hebei 14
Changsha 13
Los Angeles 13
Ann Arbor 12
Hangzhou 12
Milan 12
Seattle 11
Boardman 10
Brno 10
Brussels 8
Pune 8
Norwalk 7
Tokyo 7
Woodbridge 7
Fairfield 6
Tianjin 6
Houston 4
Berlin 3
Munich 3
Toronto 3
Verona 3
Zhengzhou 3
Borås 2
Esslingen am Neckar 2
Fuzhou 2
Kunming 2
Napoli 2
Piscataway 2
Redwood City 2
Walnut 2
Washington 2
Xi'an 2
Baghdad 1
Buffalo 1
Canberra 1
Changchun 1
Chicago 1
Den Haag 1
Des Moines 1
Edmonton 1
Falls Church 1
Genoa 1
Groningen 1
Gunzenhausen 1
Kemerovo 1
Lincoln 1
Ningbo 1
Nuremberg 1
Orange 1
Redmond 1
Riyadh 1
San Francisco 1
Shaoxing 1
Taizhou 1
Tappahannock 1
Totale 1.344
Nome #
B cells in rheumatoid arthritis. 76
Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. 69
Antinuclear antibodies in systemic sclerosis 69
B cells in rheumatoid arthritis. 66
Association of RNA Polymerase III Antibodies with Scleroderma Renal Crisis reply 62
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 60
Disease-related malnutrition in systemic sclerosis: Evidences and implications 59
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 55
Fetal programming and systemic sclerosis 54
20 years of experience with tumour necrosis factor inhibitors: what have we learned? 54
Serologic Profile and Mortality Rates of Scleroderma Renal Crisis in Italy 53
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 52
Undiagnosed connective tissue diseases High prevalence in pulmonary arterial hypertension patients 51
Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis 50
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 50
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. 50
Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis 49
Stress doppler echocardiography in systemic sclerosis: Evidence for a role in the prediction of pulmonary hypertension 49
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 47
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 47
Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al 45
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors 44
CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis 43
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 41
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 41
An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis. 39
Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability 36
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 36
Capillary leak syndrome in a patient with cancer-associated anti-transcriptional intermediary factor 1γ dermatomyositis treated with rituximab 35
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 35
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 34
Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al 33
Pathophysiology of systemic sclerosis 32
Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials 32
Pulmonary emphysema not combined with lung fibrosis in systemic sclerosis 31
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 28
Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis 26
Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno et al 25
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 16
Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience 16
Massive abdominal haemorrhage due to sequential omental vasculitis and ruptured aneurysms in a patient with granulomatosis with polyangiitis 7
Totale 1.797
Categoria #
all - tutte 7.611
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.611


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020316 89 126 3 7 0 8 2 12 3 45 18 3
2020/2021123 9 6 8 9 8 15 2 19 20 15 10 2
2021/2022183 6 1 2 4 0 9 1 6 15 4 26 109
2022/2023712 73 68 12 64 59 69 1 44 287 5 22 8
2023/2024309 35 60 10 16 13 71 15 27 0 22 8 32
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 1.797